AL
Aaron Laurita
Chief Financial OfficerMr. Aaron Laurita is Chief Financial Officer of Radiopharm Theranostics Limited from April 2026. Mr. Laurita is Chief Financial Officer of Chimeric Therapeutics Limited. Mr. Laurita is Chief Financial Officer of Immuron Limited from February 9, 2026. Mr. Laurita holds a Bachelor of Business (Professional Accountancy) from RMIT University and is a qualified Chartered Accountant and a member of Chartered Accountants Australia and New Zealand.
Positions
- Company NameImmuron LimitedStock CodeIMRNPositionChief Financial OfficerColleagues
- SGSteven George LydeamoreChief Executive Officer
- PBPaul BrennanIndependent Non-Executive Chairman
- JKJerry KanellosChief Scientific Officer
- FPFlavio PalumboChief Commercial Officer
- ALAaron LauritaChief Financial Officer
- DLDavid LyonHead of Marketing
- DPDaniel PollockIndependent Non-Executive Director
- DLDena LyrasMember of Advisory Board
- RSRavi SavarirayanIndependent Non-Executive Director
- GSGlenn S. TillotsonMember of Advisory Board
- Company NameRadiopharm Theranostics LimitedStock CodeRADXPositionChief Financial OfficerColleagues
- PEPaul Edward-Alexander HopperFounder & Executive Chairman
- RCRiccardo CanevariMD, CEO & Director
- DVDimitris VoliotisChief Medical Officer
- HGHitesh GoelHead of Project Management
- HLHester LarkinIndependent Non-Executive Director
- NPNoel P. DonnellyIndependent Non-Executive Director
- ITIan TurnerIndependent Non-Executive Director
